VisioCyt® Bladder is an AI-powered, solution designed to diagnose urothelial bladder carcinoma. By analyzing digital urine cytology, the device detects the presence of tumor cells based on their morphological atypia to predict the presence or absence of bladder cancer, and when applicable, an assessment of the tumour grade (high or low). VisioCyt® Bladder is intended to assist its prescribers in the diagnosis of patients exhibiting symptoms suggestive of bladder cancer or for individuals under surveillance for urothelial carcinoma.